As per our latest research, the global hereditary angioedema therapeutics market size reached USD 2.38 billion in 2024, driven by increasing disease awareness, novel drug approvals, and expanding therapeutic options. The market is anticipated to grow at a robust CAGR of 8.7% through the forecast period, reaching a projected value of USD 5.01 billion by 2033.
https://growthmarketreports.co....m/report/hereditary-
Me gusta
Comentario
Compartir
